Opnurasib
Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.
Product Specifications
CAS Number
2653994-08-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
526.03
Molecular Formula
C29H28ClN7O
Notes
Research use only, not for human use.
Receptor
Kras
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog